The Evolving Landscape of Factor Replacement Therapy – EAHAD
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Summer is the perfect time to catch up on the educational content you’ve been meaning to watch and stay up to date with the latest developments in haemophilia care.
One topic that continues to evolve rapidly is factor replacement therapy.
As treatment options expand, choosing the most appropriate factor VIII and factor IX replacement products and understanding how monitoring is changing has become increasingly important for delivering personalised care.
In this recorded session, Jan Astermark, Annette Bowyer and Cedric Hermans (Lon,Edin) examine the latest evidence, discuss the expanding therapeutic landscape, and explore how monitoring is evolving to support more precise, individualised treatment decisions.
What session is next on your summer learning list?”
Other posts about European Association for Haemophilia and Allied Disorders on Hemostasis Today.
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026
-
Jul 25, 2026, 12:06Christina Hart: New Review on Coagulation Disorders in Philadelphia Chromosome-Negative MPNs
-
Jul 25, 2026, 11:57Leonard Valentino: Excited to Share The New Perspectives on Hemophilic Arthropathy
-
Jul 25, 2026, 11:49Meaghan O’Donnell: Highlighting Global Gaps in Haemophilia Carrier Registration at ISTH 2026
-
Jul 25, 2026, 11:43Emmanuel J Favaloro: Honored with the JTH Distinguished Peer Review Award
-
Jul 25, 2026, 11:39Maha Othman: One Thing that Amazed Me at ISTH 2026